TCL Archive More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene August 28, 2009
TCL Archive In Brief: Calabresi Named To President’s Cancer Panel; Mays Leaves NCI Technology Office For IVAX May 5, 1995
TCL Archive Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival March 28, 2014